Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Verona Pharma to Present at 2017 Wedbush PacGrow Healthcare Conference

Verona Pharma plc
Posted on: 01 Aug 17

LONDON, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces today that Jan-Anders Karlsson, PhD, CEO of Verona Pharma, is scheduled to present at the 2017 Wedbush PacGrow Healthcare Conference.

An audio webcast of the presentation will be available on the Investors section of the company website,  www.veronapharma.com .  A replay of the webcast will be made available for 90 days following the presentation.

Event: Wedbush PacGrow Healthcare Conference
Date: August 15, 2017
Time: 3:05 PM EDT 
Location: New York, NY

About Verona Pharma plc

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.

Verona Pharma's product candidate, RPL554, is a first-in-class, inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. Verona Pharma is developing RPL554 for the treatment of chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF), and potentially asthma.

For further information, please contact:

Verona Pharma plc   Tel: +44 (0)20 3283 4200
Jan-Anders Karlsson, Chief Executive Officer    info@veronapharma.com
     
N+1 Singer (Nominated Adviser and UK Broker)   Tel: +44 (0)20 7496 3000
Aubrey Powell / James White    
     
FTI Consulting (UK Media and Investor enquiries)   Tel: +44 (0)20 3727 1000
Simon Conway / Stephanie Cuthbert / 
Natalie Garland-Collins
    veronapharma@fticonsulting.com
     
ICR, Inc. (US Media and Investor enquiries)    
James Heins    Tel: +1 203-682-8251
James.Heins@icrinc.com
Stephanie Carrington    Tel. +1 646-277-1282
Stephanie.Carrington@icrinc.com


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Verona Pharma plc via GlobeNewswire
HUG#2124724
GlobeNewswire
globenewswire.com

Last updated on: 02/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.